The Healthcare Capital & Connections Summit was founded in 2014 to connect US and Chinese companies and investors. In 2016, attendees also included companies and investors from Canada, Europe and across Asia. The Summit provides opportunities to share cross-border best practices and make connections to facilitate deals.
Pre-Summit Trip to Zhangjiang Pharma Valley Incubator to meet with an early stage pharmaceutical company residing in the incubator.
O’Melveny & Myers LLP Welcome Reception
Welcome and Opening Remarks
The Emergence of the Innovative Chinese Biotech -
Operating Models in China for Foreign Companies -
Perspective from Big Pharma -- Keynote:
Next Frontiers of Global Innovation --
The China Company’s Perspective on In-Licensing Deals --
Dinner: Sponsored by SPD Silicon Valley Bank
THURSDAY, SEPTEMBER 22, 2016
Opening Remarks -- Patrick Brennan, AdvaMed
China Medtech Local Dynamics: Expanding MNCs in China vs Globalizing Chinese Abroad
Hot Trend: Cross Border Deals Are the Rage --
Negotiating a Cross Border Deal: Key Considerations --
The China Overseas Buyer—Strategies and Considerations --
Accessing Venture Capital in China --
How Should Chinese Startups Approach International Markets? --
Will China Become the New Innovation Center in Medtech? --
The Founding Sponsors create a Summit agenda that attracts leading U.S., Chinese and global investors and healthcare companies, resulting in cross-border connections and deals.
Become a Sponsor
O’Melveny’s wide-ranging legal services encompass litigation, business deals, risk management, regulatory compliance, and government relations.
BIO is the world's largest trade association representing biotechnology companies, academic and R&D centers and related organizations. BIO hosts a portfolio of global investor and partnering events, including the BIO International Convention, world’s largest gathering of the biotechnology industry.
CEC Capital Group (formerly China eCapital Corporation) is a leading healthcare sector focused private investment bank. We provide M&A, private placement, and asset management services to clients both in and outside of China, leveraging relationships with 3,000+ institutional investors in China.
For 20+ years, Cooley has been advising clients from various industries on Greater China-related matters and cross-border transactions in the U.S., China and globally. We represent high-growth and established companies, investors and investment banks with focus on technology and life sciences.
DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their life sciences and healthcare sector legal needs around the world.
Jefferies, the global investment banking firm, has served companies and investors for over 50 years. The firm provides clients with capital markets and financial advisory services, institutional brokerage and securities research, as well as wealth management.
Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation—bringing ideas, products and services to life to advance the health and well-being of people around the world. We believe in collaboration, and that has led to breakthrough after breakthrough, from medical miracles that have changed lives, to the simple consumer products that make every day a little better.
The presenters at Healthcare Capital & Connections Summit are independent third parties and are not affiliated with SVB Financial Group. See
© 2017 SVB Financial Group. All rights reserved. SVB, SVB FINANCIAL GROUP, SILICON VALLEY BANK, MAKE NEXT HAPPEN NOW and the chevron device are trademarks of SVB Financial Group, used under license. Silicon Valley Bank is a member of the FDIC and the Federal Reserve System. Silicon Valley Bank is the California bank subsidiary of SVB Financial Group (Nasdaq: SIVB).